AHIP Final Exam - Medicare Advantage and Part D
Certification - 2026/2027 Edition | 250 Verified Questions
AHIP Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions |
Updated Per Latest CMS Guidelines | Graded A+
This comprehensive exam prep document contains 250 evidence-based questions and answers for the
AHIP Final Exam on Medicare Advantage and Part D Certification. Each question is aligned with the
latest 2026/2027 CMS guidelines and includes detailed rationales to reinforce understanding. Designed
for healthcare professionals seeking certification, this resource ensures mastery of key concepts
including plan benefits, enrollment rules, and compliance requirements. With verified solutions and a
structured format, it is an essential tool for achieving a high score.
Key Features:
Medicare Advantage plan types and benefits
Part D prescription drug coverage and formularies
Enrollment periods and eligibility rules
Marketing and compliance regulations
Star ratings and quality measures
Appeals and grievance procedures
Updates for 2026:
- Updated to reflect 2026/2027 CMS policy changes
- Incorporated new Medicare Advantage value-based insurance design models
- Revised Part D coverage gap and cost-sharing details
- Added questions on recent regulatory updates for marketing and sales
- Enhanced rationales with evidence-based citations
Abstract:
This document serves as a definitive study guide for the AHIP Final Exam on Medicare Advantage and Part D
Certification for the 2026/2027 academic year. It comprises 250 meticulously verified questions that cover all
critical domains, including plan structures, beneficiary eligibility, enrollment processes, and compliance with
federal regulations. Each question is accompanied by evidence-based answers and detailed explanations that
clarify the underlying rationale, distinguishing correct from incorrect options. The content is organized into
logical sections reflecting the exam blueprint, with emphasis on high-yield topics such as star ratings, appeals, and
marketing guidelines. Updated to incorporate the latest CMS directives, this resource ensures candidates are
prepared for both the breadth and depth of the certification exam. By systematically addressing each competency
area, it facilitates efficient study and retention, ultimately supporting successful exam outcomes. The rigorous
verification process guarantees accuracy and relevance, making it a trusted tool for healthcare professionals
seeking AHIP certification.
Keywords:
AHIP Final Exam, Medicare Advantage, Part D Certification, CMS guidelines 2026/2027, evidence-based
answers, exam prep questions, health insurance certification
Answer Format:
Each question is followed by the correct answer and a detailed rationale that explains why it is correct and why the
other options are incorrect. Rationales include references to CMS regulations and guidelines to support
evidence-based learning. Distractors are analyzed to clarify common misconceptions.
Compliance Checklist:
Page 1
, All answers verified against 2026/2027 CMS regulations
Questions cover all AHIP exam content domains
Rationales cite specific CMS guidelines and policies
Format aligns with official exam question styles
Updated to reflect recent legislative changes
No outdated or superseded information included
Content Area Overview:
Content Area Questions Key Topics Weight
Medicare Advantage Plans 1-60 Plan types, benefits, network requirements, 24%
cost-sharing, star ratings
Part D Prescription Drug 61-110 Formularies, coverage gap, cost-sharing 20%
Coverage tiers, low-income subsidies
Enrollment and Eligibility 111-150 Initial enrollment, special enrollment 16%
periods, late enrollment penalties, dual
eligibility
Marketing and Sales Compliance 151-190 Marketing guidelines, agent/broker 16%
requirements, scope of appointment,
prohibited practices
Appeals, Grievances, and 191-220 Appeal levels, grievance process, complaint 12%
Complaints tracking, timeliness standards
Regulatory and Ethical 221-250 Fraud and abuse, privacy, conflict of 12%
Considerations interest, state-specific regulations
Page 2
,Q1. A beneficiary is enrolled in a Medicare Advantage (MA) plan that includes Part D coverage.
During the annual election period (AEP), the beneficiary switches to a different MA-PD plan.
Which of the following best describes the effective date of the new plan and the disenrollment
process from the old plan?
A. The new coverage begins on January 1, and the old plan coverage ends on December 31 of the
prior year.
B. The new coverage begins on the first of the month following the plan's receipt of the enrollment
request, and disenrollment from the old plan is immediate.
C. The new coverage begins on January 1, and the old plan coverage ends on the date the new plan
enrollment is processed.
D. The new coverage begins on the first of the month after the enrollment request, but the old plan
coverage continues until the end of that month.
Correct Answer: A. The new coverage begins on January 1, and the old plan coverage ends on
December 31 of the prior year.
Rationale: During the AEP (October 15–December 7), enrollments in MA-PD plans take effect on
January 1 of the following year, and disenrollment from the prior plan also occurs on December 31.
Option A correctly states these dates. Option B is incorrect because effective dates are not immediate;
they adhere to the January 1 start. Option C is incorrect because disenrollment is not tied to processing
date. Option D describes a Special Enrollment Period rule, not AEP.
Why Wrong:
B - Effective dates for AEP enrollments are not immediate; they are standardized to January 1.
C - Disenrollment from the old plan occurs on December 31, not upon processing of the new
enrollment.
D - This describes the rule for certain Special Enrollment Periods, not the Annual Election Period.
Reference: CMS Medicare Managed Care Manual, Chapter 2, Section 30.1 (2026)
Q2. An MA plan is evaluating its Part D formulary for the upcoming plan year. Which of the
following actions would most likely violate CMS formulary requirements?
A. Removing a brand-name drug from the formulary and replacing it with a generic alternative in the
same therapeutic class.
B. Requiring prior authorization for a drug that is classified as a protected class (e.g., antidepressant).
C. Placing all drugs in a therapeutic class on a higher cost-sharing tier than the majority of other
classes.
D. Adding a new drug to the formulary mid-year without prior CMS approval.
Correct Answer: B. Requiring prior authorization for a drug that is classified as a protected class
(e.g., antidepressant).
Rationale: CMS requires that protected class drugs (antidepressants, antipsychotics, anticonvulsants,
immunosuppressants, antiretrovirals, and antineoplastics) be included on formulary without prior
authorization or step therapy. Option B violates this rule. Option A is permissible if generic is
therapeutically equivalent. Option C is allowed as long as tier placement is reasonable. Option D is
allowed for new drugs without prior approval if it is a new drug entering market.
Why Wrong:
A - Replacing a brand with a generic in the same class is generally acceptable and does not violate
formulary requirements.
C - Placing drugs on higher tiers is permissible if done consistently and with appropriate
justification.
Page 3
, D - Plans may add new drugs to formulary mid-year without prior CMS approval, though they must
notify CMS.
Reference: CMS Medicare Part D Manual, Chapter 6, Section 30.2.5 (2026)
Page 4
Certification - 2026/2027 Edition | 250 Verified Questions
AHIP Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions |
Updated Per Latest CMS Guidelines | Graded A+
This comprehensive exam prep document contains 250 evidence-based questions and answers for the
AHIP Final Exam on Medicare Advantage and Part D Certification. Each question is aligned with the
latest 2026/2027 CMS guidelines and includes detailed rationales to reinforce understanding. Designed
for healthcare professionals seeking certification, this resource ensures mastery of key concepts
including plan benefits, enrollment rules, and compliance requirements. With verified solutions and a
structured format, it is an essential tool for achieving a high score.
Key Features:
Medicare Advantage plan types and benefits
Part D prescription drug coverage and formularies
Enrollment periods and eligibility rules
Marketing and compliance regulations
Star ratings and quality measures
Appeals and grievance procedures
Updates for 2026:
- Updated to reflect 2026/2027 CMS policy changes
- Incorporated new Medicare Advantage value-based insurance design models
- Revised Part D coverage gap and cost-sharing details
- Added questions on recent regulatory updates for marketing and sales
- Enhanced rationales with evidence-based citations
Abstract:
This document serves as a definitive study guide for the AHIP Final Exam on Medicare Advantage and Part D
Certification for the 2026/2027 academic year. It comprises 250 meticulously verified questions that cover all
critical domains, including plan structures, beneficiary eligibility, enrollment processes, and compliance with
federal regulations. Each question is accompanied by evidence-based answers and detailed explanations that
clarify the underlying rationale, distinguishing correct from incorrect options. The content is organized into
logical sections reflecting the exam blueprint, with emphasis on high-yield topics such as star ratings, appeals, and
marketing guidelines. Updated to incorporate the latest CMS directives, this resource ensures candidates are
prepared for both the breadth and depth of the certification exam. By systematically addressing each competency
area, it facilitates efficient study and retention, ultimately supporting successful exam outcomes. The rigorous
verification process guarantees accuracy and relevance, making it a trusted tool for healthcare professionals
seeking AHIP certification.
Keywords:
AHIP Final Exam, Medicare Advantage, Part D Certification, CMS guidelines 2026/2027, evidence-based
answers, exam prep questions, health insurance certification
Answer Format:
Each question is followed by the correct answer and a detailed rationale that explains why it is correct and why the
other options are incorrect. Rationales include references to CMS regulations and guidelines to support
evidence-based learning. Distractors are analyzed to clarify common misconceptions.
Compliance Checklist:
Page 1
, All answers verified against 2026/2027 CMS regulations
Questions cover all AHIP exam content domains
Rationales cite specific CMS guidelines and policies
Format aligns with official exam question styles
Updated to reflect recent legislative changes
No outdated or superseded information included
Content Area Overview:
Content Area Questions Key Topics Weight
Medicare Advantage Plans 1-60 Plan types, benefits, network requirements, 24%
cost-sharing, star ratings
Part D Prescription Drug 61-110 Formularies, coverage gap, cost-sharing 20%
Coverage tiers, low-income subsidies
Enrollment and Eligibility 111-150 Initial enrollment, special enrollment 16%
periods, late enrollment penalties, dual
eligibility
Marketing and Sales Compliance 151-190 Marketing guidelines, agent/broker 16%
requirements, scope of appointment,
prohibited practices
Appeals, Grievances, and 191-220 Appeal levels, grievance process, complaint 12%
Complaints tracking, timeliness standards
Regulatory and Ethical 221-250 Fraud and abuse, privacy, conflict of 12%
Considerations interest, state-specific regulations
Page 2
,Q1. A beneficiary is enrolled in a Medicare Advantage (MA) plan that includes Part D coverage.
During the annual election period (AEP), the beneficiary switches to a different MA-PD plan.
Which of the following best describes the effective date of the new plan and the disenrollment
process from the old plan?
A. The new coverage begins on January 1, and the old plan coverage ends on December 31 of the
prior year.
B. The new coverage begins on the first of the month following the plan's receipt of the enrollment
request, and disenrollment from the old plan is immediate.
C. The new coverage begins on January 1, and the old plan coverage ends on the date the new plan
enrollment is processed.
D. The new coverage begins on the first of the month after the enrollment request, but the old plan
coverage continues until the end of that month.
Correct Answer: A. The new coverage begins on January 1, and the old plan coverage ends on
December 31 of the prior year.
Rationale: During the AEP (October 15–December 7), enrollments in MA-PD plans take effect on
January 1 of the following year, and disenrollment from the prior plan also occurs on December 31.
Option A correctly states these dates. Option B is incorrect because effective dates are not immediate;
they adhere to the January 1 start. Option C is incorrect because disenrollment is not tied to processing
date. Option D describes a Special Enrollment Period rule, not AEP.
Why Wrong:
B - Effective dates for AEP enrollments are not immediate; they are standardized to January 1.
C - Disenrollment from the old plan occurs on December 31, not upon processing of the new
enrollment.
D - This describes the rule for certain Special Enrollment Periods, not the Annual Election Period.
Reference: CMS Medicare Managed Care Manual, Chapter 2, Section 30.1 (2026)
Q2. An MA plan is evaluating its Part D formulary for the upcoming plan year. Which of the
following actions would most likely violate CMS formulary requirements?
A. Removing a brand-name drug from the formulary and replacing it with a generic alternative in the
same therapeutic class.
B. Requiring prior authorization for a drug that is classified as a protected class (e.g., antidepressant).
C. Placing all drugs in a therapeutic class on a higher cost-sharing tier than the majority of other
classes.
D. Adding a new drug to the formulary mid-year without prior CMS approval.
Correct Answer: B. Requiring prior authorization for a drug that is classified as a protected class
(e.g., antidepressant).
Rationale: CMS requires that protected class drugs (antidepressants, antipsychotics, anticonvulsants,
immunosuppressants, antiretrovirals, and antineoplastics) be included on formulary without prior
authorization or step therapy. Option B violates this rule. Option A is permissible if generic is
therapeutically equivalent. Option C is allowed as long as tier placement is reasonable. Option D is
allowed for new drugs without prior approval if it is a new drug entering market.
Why Wrong:
A - Replacing a brand with a generic in the same class is generally acceptable and does not violate
formulary requirements.
C - Placing drugs on higher tiers is permissible if done consistently and with appropriate
justification.
Page 3
, D - Plans may add new drugs to formulary mid-year without prior CMS approval, though they must
notify CMS.
Reference: CMS Medicare Part D Manual, Chapter 6, Section 30.2.5 (2026)
Page 4
